Xuemeng Xu

发表

The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials

Q. Liao, Yujuan Zhou, X. Li, 2023, Frontiers in Oncology.

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9

Min Su, Qiang Liu, Q. Liao, 2022, Cancer science.

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment

Q. Liao, D. Cao, Yujuan Zhou, 2023, Journal of Experimental & Clinical Cancer Research.

Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma

Min Su, Q. Liao, Yujuan Zhou, 2023, Aging.

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

Q. Liao, Yujuan Zhou, Yanyan Tang, 2023, Experimental & molecular medicine.

Organoids: opportunities and challenges of cancer therapy

Min Su, Q. Liao, Yujuan Zhou, 2023, Frontiers in cell and developmental biology.

Cellular metabolism: A key player in cancer ferroptosis

Q. Liao, Yujuan Zhou, Yanyan Tang, 2024, Cancer communications.

Endoplasmic reticulum stress—a key guardian in cancer

Q. Liao, Yujuan Zhou, Yanyan Tang, 2024, Cell death discovery.

Altered glycosylation in cancer: molecular functions and therapeutic potential

Q. Liao, Yujuan Zhou, Yanyan Tang, 2024, Cancer communications.